Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.Cancer Discovery|January 10, 2015
JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic responseMaria Kleppe, Minsuk Kwak, Priya Koppikar, et al.Blood Advances|December 12, 2018
PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.Current Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2026
Selinexor Plus Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis: Phase 3 SENTRY TrialPrithviraj Bose, Haris Ali, Haifa Kathrin Al-Ali, et al.Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.Cancer Cell|December 19, 2017
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative NeoplasmsMaria Kleppe, Richard Koche, Lihua Zou, et al.Blood|July 7, 2017
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosisMatthias Papo, Eli L Diamond, Fleur Cohen-Aubart, et al.Pageof 8